TNF and myeloid sarcoma: We noticed that compared with healthy controls, the contents of proinflammatory cytokines, such as IL-17 and TNF-α, were significantly increased (Padj < 0.001), whereas those of IL-12 were prominently decreased (Padj < 0.01) in patients with MS (Figure 5).